Anne Marie Falk

Array ( [id] => 9149074 [patent_doc_number] => 20130303597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'SDF-1 DELIVERY FOR TREATING ISCHEMIC TISSUE' [patent_app_type] => utility [patent_app_number] => 13/912435 [patent_app_country] => US [patent_app_date] => 2013-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30225 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13912435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490179 [patent_doc_number] => 20120289586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'SDF-1 Delivery For Treating Ischemic Tissue' [patent_app_type] => utility [patent_app_number] => 13/556639 [patent_app_country] => US [patent_app_date] => 2012-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18023 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13556639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490177 [patent_doc_number] => 20120289585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'SDF-1 Delivery For Treating Ischemic Tissue' [patent_app_type] => utility [patent_app_number] => 13/556595 [patent_app_country] => US [patent_app_date] => 2012-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18021 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13556595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691624 [patent_doc_number] => 08822216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'DNA regulatory element for the expression of transgenes in neurons of a subject and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/409066 [patent_app_country] => US [patent_app_date] => 2012-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 82 [patent_no_of_words] => 45787 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13409066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265271 [patent_doc_number] => 20120164701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'RENEWABLE CHEMICALS AND FUELS FROM OLEAGINOUS YEAST' [patent_app_type] => utility [patent_app_number] => 13/406417 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 49223 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13406417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8491738 [patent_doc_number] => 20120291145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'TRANSGENIC MICE OVER-EXPRESSING RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCT (RAGE) IN BRAIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/362542 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13399 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13362542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817997 [patent_doc_number] => 20120064617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'SYSTEM AND METHOD FOR CONTINUOUS FERMENTATION OF ALGAE' [patent_app_type] => utility [patent_app_number] => 13/299844 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3069 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064617.pdf [firstpage_image] =>[orig_patent_app_number] => 13299844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7786033 [patent_doc_number] => 20120047589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'METHOD OF DELIVERY OF NUCLEIC ACIDS TO A DEVELOPING EMBRYO' [patent_app_type] => utility [patent_app_number] => 13/283342 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4850 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20120047589.pdf [firstpage_image] =>[orig_patent_app_number] => 13283342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8059751 [patent_doc_number] => 20120079615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'KNOCK-IN MICE WITH INDUCIBLE LOSS OF EOSINOPHILS' [patent_app_type] => utility [patent_app_number] => 13/240128 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5775 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20120079615.pdf [firstpage_image] =>[orig_patent_app_number] => 13240128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791012 [patent_doc_number] => 20120052568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Non-Static Suspension Culture of Cell Aggregates' [patent_app_type] => utility [patent_app_number] => 13/217052 [patent_app_country] => US [patent_app_date] => 2011-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 25630 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052568.pdf [firstpage_image] =>[orig_patent_app_number] => 13217052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114401 [patent_doc_number] => 08158416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'CDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses, and process for the production of such viruses encoding additional antigenically active proteins' [patent_app_type] => utility [patent_app_number] => 13/175307 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 14782 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158416.pdf [firstpage_image] =>[orig_patent_app_number] => 13175307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561322 [patent_doc_number] => 20110275155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'ENTRAPPED STEM CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/156659 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3911 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275155.pdf [firstpage_image] =>[orig_patent_app_number] => 13156659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8159239 [patent_doc_number] => 20120100607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'COMPOSITIONS OF ADULT DISC STEM CELLS AND METHODS FOR THE TREATMENT OF DEGENERATIVE DISC DISEASE' [patent_app_type] => utility [patent_app_number] => 13/113599 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21206 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100607.pdf [firstpage_image] =>[orig_patent_app_number] => 13113599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048804 [patent_doc_number] => 20110207802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'GLUTAMIC ACID DECARBOXYLASE (GAD) BASED DELIVERY SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/095273 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 28589 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207802.pdf [firstpage_image] =>[orig_patent_app_number] => 13095273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328467 [patent_doc_number] => 08236563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'Methods of differentiating and protecting cells by modulating the p38/MEF2 pathway' [patent_app_type] => utility [patent_app_number] => 13/077752 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 33 [patent_no_of_words] => 20034 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13077752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6057898 [patent_doc_number] => 20110113496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TRANSGENIC NON-HUMAN ANIMAL AND METHODS FOR STEM CELL ENGRAFTMENT' [patent_app_type] => utility [patent_app_number] => 12/942666 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14193 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20110113496.pdf [firstpage_image] =>[orig_patent_app_number] => 12942666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7796122 [patent_doc_number] => 08124829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/908832 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 33 [patent_no_of_words] => 13261 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124829.pdf [firstpage_image] =>[orig_patent_app_number] => 12908832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616759 [patent_doc_number] => 20100310627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Xenotransplant for Stroke Therapy' [patent_app_type] => utility [patent_app_number] => 12/858180 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15174 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310627.pdf [firstpage_image] =>[orig_patent_app_number] => 12858180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6379762 [patent_doc_number] => 20100316603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Combination Immunogene Therapy' [patent_app_type] => utility [patent_app_number] => 12/850802 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24156 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316603.pdf [firstpage_image] =>[orig_patent_app_number] => 12850802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6009087 [patent_doc_number] => 20110061119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'METHOD OF PRODUCING NON-HUMAN MAMMALS' [patent_app_type] => utility [patent_app_number] => 12/849472 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7311 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20110061119.pdf [firstpage_image] =>[orig_patent_app_number] => 12849472 [rel_patent_id] =>[rel_patent_doc_number] =>)